On the inhibitory affect of some dementia drugs on DNA polymerase β activity

Neurochemical Research

Volumn 33, Issue 11, 2008, Pages 2187-2196

  Vyjayanti, V N ^a   Chary, N S ^a   Rao, Kalluri Subba ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Brain; Dementia; DNA gap repair; DNA polymerase ; Drugs

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; DONEPEZIL; LYASE; NUCLEOTIDE; PIRACETAM; RIVASTIGMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DEMENTIA; DNA REPAIR; DRUG ACTIVITY; DRUG BINDING; DRUG HALF LIFE; ENZYME ACTIVITY; EXCISION REPAIR; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

ANIMALS; BASE SEQUENCE; DEMENTIA; DNA POLYMERASE BETA; DNA PRIMERS; DNA REPAIR; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; RATS;

EID: 52549087845     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9587-3     Document Type: Article

References (45)

1. KS Rao 2007 Mechanisms of disease: DNA-repair defects and neurological disease Nat Clin Pract Neurol 3 162 172
2. J Waser U Hubscher CC Kuenzle 1979 DNA polymerase β from brain neurons is a repair enzyme Eur J Biochem 97 2 361 368
3. KS Rao VV Annapurna NS Raji 2000 Loss of base excision repair in aging rat neurons and its restoration by DNA polymerase β Brain Res Mol Brain Res 85 1-2 251 259
4. K Subrahmanyam KS Rao 1988 On the type of DNA polymerase activity in neuronal, astroglial and oligodendroglial cell fractions from young, adult and old rat brains Biochem Intl 16 6 1111 1117
5. NS Raji T Hari Krishna KS Rao 2002 DNA-polymerase α,β,δ and ε activities in isolated neuronal and astroglial cell fractions from developing and aging rat cerebral cortex Int J Dev Neurosci 20 6 491 496
6. KV Subba Rao KS Rao 1984 Increased DNA polymerase β activity in different regions of aging rat brain Biochem Intl 9 3 391 397
7. DS Wishart C Knox AC Guo 2006 DrugBank: a comprehensive resource for in silico drug discovery and exploration Nucleic Acids Res 34 Database issue D668 D672
8. S Akasofu M Kimura T Kosasa 2006 Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity Eur J Pharmacol 530 3 215 222
9. M Kimura S Akasofu H Ogura 2005 Protective effect of donepezil against Abeta (1-40) neurotoxicity in rat septal neurons Brain Res 1047 1 72 84
10. P Kasa H Papp P Kasa Jr 2000 Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain Neuroscience 101 1 89 100
11. M Kenji M Mannen N yasushi 1999 Absorption, distribution, metabolism, and excretion of donepezil (aricept) after a single oral administration to rat Drug Metab Dispos 27 12 1406 1414
12. J Poirier 2002 Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action Int J Clin Pract 127 Suppl 6 19
13. MF Eskander NG Nagykery EY Leung 2005 Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles Brain Res 1060 1-2 144 152
14. CM Spencer S Noble 1998 Rivastigmine. A review of its use in Alzheimer's disease Drugs Aging 13 5 391 411
15. NH Greig T Utsuki Q Yu 2001 A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase Curr Med Res Opin 17 3 159 165
16. R Moretti P Torre RM Antonello 2001 Rivastigmine in sub cortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow up Eur J Neurol 8 4 361 362
17. J Andin A Enz C Gentsch 2005 Rivastigmine as a modulator of the neuronal glutamate transporter rEAAC1 mRNA expression Dement Geriatr Cogn Disord 19 1 18 23
18. B Langguth E Bauer S Feix 2007 Modulation of human motor cortex excitability by the cholinesterase inhibitor rivastigmine Neurosci Lett 415 1 40 44
19. http://www.pharma.us.novartis.com/product/pi/pdf/exelonpatch.pdf
20. O Buresova J Bures 1976 Piracetam induced facilitation of inter hemispheric transfer of visual information in rats Psychopharmacologia 46 1 93 102
21. AH Gouliaev A Senning 1994 Piracetam and other structurally related nootropics Brain Res Brain Res Rev 19 2 180 222
22. W Deberdt 1994 Interaction between psychological and pharmacological treatment in cognitive impairment Life Sci 55 25-26 2057 2066
23. Herrschaft H (1989) Effects and therapeutic efficacy of nootropic drugs in acute and chronic cerebral ischemia in man. In: Kriegelstein J (ed) Pharmacology of cerebral ischemia. CRC Press, Boca Raton
24. D Platt J Horn JD Summa 1993 On the efficacy of Piracetam in geriatric patients with acute cerebral ischemia: a clinically controlled double blind study Arch Gerontol Geriatr 16 2 149 164
25. G Chouinard L Annable A Ross-Chouinard 1983 Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment Psychopharmacol 81 2 100 106
26. MT Tacconi RJ Wurtman 1984 Physiological disposition of oral piracetam in Sprague-Dawley rats J Pharm Pharmacol 36 10 659 662
27. AJ Stegink 1972 The clinical use of Piracetam, a new nootropic drug. The treatment of symptoms of senile involution Arzneimittelforschung 22 6 975 977
28. B Croisile M Trillet J Fondarai 1993 Long-term and high dose piracetam treatment of Alzheimer's disease Neurol 43 2 301 305
29. M Moriau E Lavenne-Pardonge L Crasborn 1993 Treatment of the Raynaud's phenomenon with Piracetam Arzneimittelforschung 43 5 526 535
30. G Pepeu G Spignoli 1990 Neurochemical actions of nootropic drugs Adv Neurol 51 247 252
31. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254
32. MR Sawaya R Prasad SH Wilson 1997 Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism Biochemistry 36 37 11205 11215
33. HM Berman J Westbrook Z Feng 2000 The protein data bank Nucl Acids Res 28 1 235 242
34. D Schneidman-Duhovny Y Inbar R Nussinov 2005 PatchDock and SymmDock: servers for rigid and symmetric docking Nucl Acids Res 33 363 367
35. Duhovny D, Nussinov R, Wolfson HJ (2002) Efficient Unbound Docking of Rigid Molecules. In: Gusfield et al (ed) Proceedings of the 2nd Workshop on Algorithms in Bioinformatics(WABI) Rome, Italy, Lecture Notes in Computer Science, Springer Verlag 2452:185-200
36. ArgusLab 4.0.1 Mark A. Thompson Planaria Software LLC, Seattle, WA
37. DeLano WL (2002) The PyMOL Molecular Graphics System on World Wide Web http://www.pymol.org
38. R Prasad WA Beard JY Chyan 1998 Functional analysis of the amino-terminal 8-kDa domain of DNA polymerase β as revealed by site-directed mutagenesis. DNA binding and 5′-deoxyribose phosphate lyase activities J Biol Chem 273 18 11121 11126
39. T Hari Krishna Hemkal Anjana KS Rao 2004 The presence of 3′-5′ exonuclease activity in rat brain neurons and its role in template driven extension of 3′ mismatched primers by DNA Polymerase β in aging neurons Neurochem Res 29 4 761 770
40. T Hari Krishna S Mahipal A Sudhakar 2005 Reduced gap repair in aging rat neuronal extracts and its restoration by DNA polymerase β and DNA ligase J Neurochem 92 4 818 823
41. A Beard William H Wilson Samuel 2000 Structural design of a eukaryotic DNA repair polymerase: DNA polymerase β Mutat Res 460 231 244
42. T Pui Yan Y Mengsu 2002 Kinetic study of various binding modes between human DNA polymerase β and different DNA substrates by surface-plasmon- resonance biosensor Biochem J 361 317 325
43. JJ Maria G Roberto B Wlodzimierz 2002 Dynamics of Gapped DNA Recognition by Human Polymerase β J Biol Chem 277 23 20316 20327
44. MJ Jezewska S Rajendran W Bujalowski 2001 Energetics and specificity of rat DNA polymerase β interactions with template-primer and gapped DNA substrates J Biol Chem 276 19 16123 16136
45. SH Wilson 1998 Mammalian base excision repair and DNA polymerase beta Mutat Res 407 203 215